Results 221 to 230 of about 135,947 (293)
Momelotinib demonstrated robust real‐world activity after ruxolitinib failure, with clinically meaningful improvements in spleen (≥50% spleen length reduction, 30.0%), symptoms (≥50% total symptoms score reduction, 39.2%), and anemia (major response, 35.7%) at 6 months.
Francesca Palandri +41 more
wiley +1 more source
PLR/SII/D-dimer iron triangle: a novel precision prediction strategy for <i>Mycoplasma pneumoniae</i> pneumonia-associated plastic bronchitis in children. [PDF]
Feng M +6 more
europepmc +1 more source
The Beginnings of Bronchitis [PDF]
openaire +2 more sources
A case of severe Mycoplasma pneumoniae pneumonia complicated by necrotizing tracheobronchitis with a review of the literature. [PDF]
Gao C +5 more
europepmc +1 more source
Randomized, Double-Blind, Multicenter, Phase 3 Study of AG NPP709 Compared With Ivy Leaf Extract in Patients With Acute or Chronic Respiratory Symptoms. [PDF]
Cho YJ +5 more
europepmc +1 more source
Increased serum antibody responses to Aspergillus fumigatus and house dust mite antigens in dogs with idiopathic eosinophilic bronchopneumopathy. [PDF]
Canonne AM +7 more
europepmc +1 more source
Hidden Ethnomedicinal Diversity in a Fine-Scale Study from Konak, Eastern Anatolia. [PDF]
Kolaç T, Sadikoğlu N, İçen MS.
europepmc +1 more source

